Mumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration ...

Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

OMD India has been chosen by Piramal Pharma to manage its integrated media mandate, focusing on enhancing the presence of its OTC brands. The agency’s strategic marketing and media efforts aim to ...

OMD India will lead the strategic marketing and media efforts for the company's portfolio of OTC brands, including Lacto ...

As part of the mandate, OMD will focus on improving Piramal Pharma’s market presence, brand awareness, consumer engagement, ...

Piramal Pharma has awarded its integrated media mandate to OMD India, part of Omnicom Media Group. Following a multi-round ...

Dentsu has allocated $328 million to rebuild the business in 2025, with a further $295 million to be invested over the next ...

India is one of the oldest civilisations in the world with a 5,000-year history. When we transitioned to democracy, we ...